Patents Assigned to Ontogeny, Inc.
  • Pharmaceutical compositions containing hedgehog protein
    Patent number: 6207718
    Abstract: A composition of a hedgehog protein which includes as an additive cyclodextrin, a non-ionic detergent, an anionic saccharide and/or ionic salt containing zinc ions, magnesium ions, calcium ions and/or sulfate ions is especially stable at room temperature.
    Type: Grant
    Filed: August 2, 1999
    Date of Patent: March 27, 2001
    Assignee: Ontogeny, Inc.
    Inventor: Apollon Papadimitriou
  • Insulin promoter factor, and uses related thereto
    Patent number: 6197945
    Abstract: The present invention relates to the discovery in eukaryotic cells, particularly mammalian cells, of novel a transcriptional regulatory factor, referred to hereinafter as “Insulin Promoter Factor 1” or “Ipf1”.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: March 6, 2001
    Assignee: Ontogeny, Inc.
    Inventor: Thomas Edlund
  • Analysis of gene expression, methods and reagents therefor
    Patent number: 5981190
    Abstract: The present invention is directed to methods and reagents for performing rapid, detailed analysis of the spatial and temporal expression of genes. The method uses linker tags in a head to tail array in a serial analysis of gene expression.
    Type: Grant
    Filed: January 8, 1998
    Date of Patent: November 9, 1999
    Assignee: Ontogeny, Inc.
    Inventor: David I. Israel
  • Method of isolating bile duct progenitor cells
    Patent number: 5861313
    Abstract: The present invention relates to a substantially pure population of viable bile duct progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 19, 1999
    Assignee: Ontogeny, Inc.
    Inventors: Kevin K. Pang, Monica W. Homa
  • Insulin promoter factor, and uses related thereto
    Patent number: 5849989
    Abstract: The present invention relates to the discovery in eukaryotic cells, particularly mammalian cells, of novel a transcriptional regulatory factor, referred to hereinafter as "Insulin Promoter Factor 1" or "Ipf1".
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: December 15, 1998
    Assignee: Ontogeny, Inc.
    Inventor: Thomas Edlund